Literature DB >> 15469316

Synthesis of a C4-epi-C1-C6 fragment of FR901464 using a novel bromolactolization.

Brian J Albert1, Kazunori Koide.   

Abstract

[reaction: see text] A synthesis of a C4-epi-C1-C6 fragment of the antitumor agent FR901464 is reported. The advanced intermediate prepared in this study contains two of the three correct stereocenters found in the C1-C6 moiety of FR901464. For the preparation of this intermediate, we have developed a highly diastereoselective bromolactolization of a delta-alkenyl ketone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469316     DOI: 10.1021/ol049160w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue.

Authors:  Brian J Albert; Ananthapadmanabhan Sivaramakrishnan; Tadaatsu Naka; Nancy L Czaicki; Kazunori Koide
Journal:  J Am Chem Soc       Date:  2007-02-06       Impact factor: 15.419

2.  Synthetic mRNA splicing modulator compounds with in vivo antitumor activity.

Authors:  Chandraiah Lagisetti; Alan Pourpak; Tinopiwa Goronga; Qin Jiang; Xiaoli Cui; Judith Hyle; Jill M Lahti; Stephan W Morris; Thomas R Webb
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

3.  Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.

Authors:  Sami Osman; Brian J Albert; Yanping Wang; Miaosheng Li; Nancy L Czaicki; Kazunori Koide
Journal:  Chemistry       Date:  2010-11-19       Impact factor: 5.236

4.  Enantioselective syntheses of FR901464 and spliceostatin A: potent inhibitors of spliceosome.

Authors:  Arun K Ghosh; Zhi-Hua Chen
Journal:  Org Lett       Date:  2013-09-19       Impact factor: 6.005

5.  Enantioselective Synthesis of Spliceostatin G and Evaluation of Bioactivity of Spliceostatin G and Its Methyl Ester.

Authors:  Arun K Ghosh; Guddeti Chandrashekar Reddy; Andrew J MacRae; Melissa S Jurica
Journal:  Org Lett       Date:  2017-12-08       Impact factor: 6.005

6.  Cyclic Acetal Formation Between 2-Pyridinecarboxaldehyde and gamma-Hydroxy-alpha,beta-Acetylenic Esters.

Authors:  Sami Osman; Kazunori Koide
Journal:  Tetrahedron Lett       Date:  2008-11-10       Impact factor: 2.415

7.  Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.

Authors:  Brian J Albert; Peter A McPherson; Kristine O'Brien; Nancy L Czaicki; Vincent Destefino; Sami Osman; Miaosheng Li; Billy W Day; Paula J Grabowski; Melissa J Moore; Andreas Vogt; Kazunori Koide
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

8.  Enantioselective Synthesis of Thailanstatin A Methyl Ester and Evaluation of in Vitro Splicing Inhibition.

Authors:  Arun K Ghosh; Anne M Veitschegger; Shenyou Nie; Nicola Relitti; Andrew J MacRae; Melissa S Jurica
Journal:  J Org Chem       Date:  2018-04-26       Impact factor: 4.354

Review 9.  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

Authors:  Arun K Ghosh; Jennifer L Mishevich; Melissa S Jurica
Journal:  J Nat Prod       Date:  2021-05-11       Impact factor: 4.803

10.  Enantioselective total syntheses of FR901464 and spliceostatin A and evaluation of splicing activity of key derivatives.

Authors:  Arun K Ghosh; Zhi-Hua Chen; Kerstin A Effenberger; Melissa S Jurica
Journal:  J Org Chem       Date:  2014-05-30       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.